4
Changes in Ownership
Royalty Pharma plc Filed Acc 0001814876-26-000002
EVP & CFO sold 69,582 shares at $38.42 ($2,673,041)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Coyne Terrance P. · EVP & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Sale : show line 1 in the form 10b5-1 | −65,832 | $38.42 | $2,528,982 | 460,828 | I |
| 2026-01-02 | Sale : show line 2 in the form 10b5-1 | −3,750 | $38.42 | $144,059 | 39,760 | I |
| Open-market sales · 69,582 sh · avg $38.42 · $2,673,041 | ||||||
Loading xslF345X05/wk-form4_1767734318.xml…